Gold vs US Dollar

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NASDAQ
Halozyme Therapeutics Incorporated (HALO)
Halozyme Therapeutics Incorporated (HALO) Financials

HALO Halozyme Therapeutics Incorporated

42.56

-1.28 (-2.92%)

11 May 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-46.48	16.116	-16.732	-14.36	22.532	47.818	13.723	15.754
Return on Equity (%)	-1958.985	71.605	-35.136	-42.413	106.325	231.443	110.227	222.072
Return on Invested Capital (%)	-73.086	33.357	-23.048	-18.219	48.036	90.275	21.951	22.224
Operating Margin (%)	-55.821	26.403	-40.663	-30.932	55.935	57.757	40.275	44.268
Net Profit Margin (%)	-70.231	19.889	-52.897	-36.859	48.239	90.842	30.62	33.958
Book Value Per Share	-0.236	1.38	1.628	0.633	1.055	1.352	-5.482	-5.744
Earnings Per Share	-0.748	0.417	-0.525	-0.499	0.901	2.764	1.41	2.007
Cash Per Share	0.485	1.118	0.379	0.829	1.031	0.815	1.634	0.844
Working Capital Per Share	1.467	2.51	1.821	3.159	0.931	5.554	4.243	4.519
Operating Profit Per Share	0.842	1.905	0.942	1.066	1.588	2.505	3.678	4.619
EBIT Per Share	-0.74	0.408	-0.522	-0.499	0.903	1.706	1.736	2.483
EBITDA Per Share	-0.74	0.408	-0.522	-0.499	0.903	1.706	1.736	2.483
Free Cash Flow Per Share	-0.743	0.412	-0.51	-0.499	0.896	2.754	1.097	1.511

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	4.7	3.886	2.865	6.346	1.317	7.907	5.65	6.635
Quick Ratio	4.043	3.741	2.575	5.613	1.089	7.101	4.203	5.06
Inventory Turnover (Days)	36.385	5.932	54.379	54.676	82.859	44.385	55.361	56.164
Shares Outstanding	129.5M	142.79M	144.73M	136.71M	135.03M	137.5M	135.15M	N/A

Key Stats and Ratios

Year End 31 December 2023	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	N/A	N/A	135.21M	135.15M	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	64.946	N/A	N/A	N/A	35.019	N/A	N/A	N/A
Net Profit Margin (%)	51.252	N/A	N/A	N/A	24.432	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	8.852	N/A	N/A	N/A	6.691	N/A	N/A	N/A
Quick Ratio	8.057	N/A	N/A	N/A	4.767	N/A	N/A	N/A
Inventory Turnover (Days)	148.644	N/A	N/A	N/A	242.04	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	5.47B
Price to Earnings Ratio	19.43
Price to Sales Ratio	6.6
Price to Cash Ratio	46.23
Price to Book Ratio	65.3
Dividend Yield	-

Share Statistics

Shares Outstanding	126.82M
Average Volume (1 week)	1.35M
Average Volume (1 Month)	911.87k
52 Week Change	32.46%
52 Week High	45.00
52 Week Low	31.05

More Ratios Coming Soon!

Halozyme Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions